Standout Papers

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment w... 2013 2026 2017 2021 534
  1. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents (2013)
    Hui Yang, Carlos E. Bueso‐Ramos et al. Leukemia

Immediate Impact

1 by Nobel laureates 21 from Science/Nature 62 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Inhibition of fatty acid oxidation enables heart regeneration in adult mice
2023 StandoutNature
2 intermediate papers

Works of Sherry Pierce being referenced

Ruxolitinib in combination with Lenalidomide as therapy for patients with myelofibrosis
2015
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
2013

Author Peers

Author Last Decade Papers Cites
Sherry Pierce 3425 1315 1762 129 4.4k
R Ohno 4067 1127 2152 102 5.7k
Ellin Berman 2186 983 1225 99 3.7k
Claude Gardin 3177 1097 1922 120 4.2k
Vinod Pullarkat 3641 1311 1871 225 5.8k
Olatoyosi Odenike 2102 1051 1557 151 3.5k
David Bowen 4295 1692 2110 127 5.3k
Felicetto Ferrara 3863 989 2564 193 5.6k
Keisuke Toyama 4525 1742 2362 156 6.7k
Guido Kobbe 3699 1313 1101 200 5.1k
Tibor Kovacsovics 2269 634 1331 123 3.6k

All Works

Loading papers...

Rankless by CCL
2026